Skip to content

Experience From the Italian S-ICD Registry

Experience From the Long-term Italian Subcutaneous Implantable Cardioverter Defibrillator Registry (ELISIR)

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04373876
Acronym
ELISIR
Enrollment
500
Registered
2020-05-05
Start date
2020-01-01
Completion date
2022-12-31
Last updated
2021-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Arrest, Implantable Cardiac Defibrillator, Sudden Cardiac Death, Ventricular Arrythmia

Brief summary

The purpose of this registry is to collect data on implant parameters, early, mid and long-term clinical effectiveness of Subcutaneous Implantable Cardioverter Defibrillator (S-ICD) therapies in order to better understand how to improve the clinical care of patients and effectiveness of S-ICD therapies.

Detailed description

ISIR is an observational, multicentric registry designed to collect implant and follow-up data of consecutive patients implanted with Subcutaneous Implantable Cardioverter Defibrillator (S-ICD). A number of about 10 enrolling centers is estimated with an overall number of 400 patients. A minimal follow-up of 6 months is required before analyzing clinical outcomes. The data analysis will focus on implant outcomes and early, mid and long-term effectiveness of S-ICD therapies and safety.

Interventions

Patients implanted with a totally subcutaneous defibrillator system

Sponsors

Luigi Sacco University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \>/= 18 years * Patients successfully implanted with S-ICD * Patients able to provide written informed consent or have informed consent as provided by a legal representative

Design outcomes

Primary

MeasureTime frameDescription
Mortality2 yearsOverall or arrhythmic mortality
Appropriate shocks2 yearsAppropriate therapies delivered by the devices
Inappropriate shocks2 yearsInappropriate therapies delivered by the devices

Countries

France, Germany, Italy, Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 16, 2026